Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank17
3Y CAGR-73.6%
5Y CAGR-61.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-73.6%/yr
Annual compound
5Y CAGR
-61.4%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 0.52% |
| 2024 | 3.85% |
| 2023 | 17.67% |
| 2022 | 28.20% |
| 2021 | 37.82% |
| 2020 | 60.39% |
| 2019 | 0.00% |